etoposide has been researched along with Franklin Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamaguchi, H; Kato, A; Mikoshiba, M; Nagata, K; Nakane, M; Takano, H | 1 |
| Hirai, M; Ishikawa, K; Kumakawa, T; Masami, M; Mori, M; Tsutsumi, H | 1 |
2 other study(ies) available for etoposide and Franklin Disease
| Article | Year |
|---|---|
Combination of rituximab and chemotherapy showing anti-tumor effect in gamma heavy chain disease expressing CD20.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Fatal Outcome; Heavy Chain Disease; Humans; Immunoglobulin gamma-Chains; Male; Prednisone; Procarbazine; Rituximab | 2008 |
[Successful treatment of heavy-chain disease with etoposide].
Topics: Administration, Oral; Aged; Etoposide; Heavy Chain Disease; Humans; Male | 1997 |